- Home
- VLTO vs PODD Comparison
VLTO vs PODD Comparison
Compare VLTO & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VLTO | PODD |
|---|---|---|
| Founded | 2023 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5B | 22.1B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | VLTO | PODD |
|---|---|---|
| Price | $102.29 | $288.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 19 |
| Target Price | $113.25 | ★ $366.58 |
| AVG Volume (30 Days) | ★ 1.8M | 706.4K |
| Earning Date | 02-03-2026 | 11-06-2025 |
| Dividend Yield | ★ 0.51% | N/A |
| EPS Growth | ★ 12.64 | N/A |
| EPS | ★ 3.65 | 3.45 |
| Revenue | ★ $5,452,000,000.00 | $2,521,800,000.00 |
| Revenue This Year | $8.28 | $32.55 |
| Revenue Next Year | $5.74 | $20.39 |
| P/E Ratio | ★ $28.03 | $83.70 |
| Revenue Growth | 6.15 | ★ 27.11 |
| 52 Week Low | $83.87 | $230.05 |
| 52 Week High | $110.11 | $354.88 |
Technical Indicators
Market Signals| Indicator | VLTO | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 57.43 | 37.94 |
| Support Level | $99.47 | $285.02 |
| Resistance Level | $101.75 | $292.75 |
| Average True Range (ATR) | 1.71 | 7.73 |
| MACD | 0.35 | -0.52 |
| Stochastic Oscillator | 83.26 | 12.27 |
Price Performance
Historical ComparisonAbout VLTO Veralto Corp
Veralto is a diversified industrial firm organized into two segments, water quality as well as product quality and innovation. The water quality segment offers water analytics and water treatment solutions, while the product quality and innovation segment offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company has around 17,000 employees. Veralto generated approximately $5.2 billion in revenue in 2024.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.